Child Healthcare Assoc.

Syracuse, New York 13057

0 studies enrolling now · 1 studies all time

What they study most

Human Metapneumovirus and Human Parainfluenza Infection

Studies at this site

• Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure — Completed